Requirement of phosphatidylcholine for normal progression through the cell cycle in C3H/10T1/2 fibroblasts.
We have investigated the possible requirement of phosphatidylcholine for normal progression through the cell cycle of C3H/10T1/2 fibroblasts. Incubation of the cells in a medium with 0.5% serum synchronized the cells in the G0 stage of the cell cycle. Supplementation of the cells with 10% dialyzed and delipidated serum +/- choline resulted in normal cell division and growth for cells with choline, whereas cell division was markedly impaired in the absence of choline. Flow cytofluorometry analysis indicated that after 4 days in the absence of choline, 85% of the fibroblasts were in the G1 phase. Addition of choline resulted in synchronous synthesis of DNA with a peak occurring after 14 h. Incubation of cells with 0.5% serum had no effect on phosphatidylcholine (PC) levels in cells supplemented with 28 microM choline, but the concentration of PC was reduced from 32 to 20 nmol/10(6) cells after 1 day of incubation in the absence of choline. Supplementation with dialyzed serum, but not dialyzed and delipidated serum, allowed choline-deficient cells to replicate normally. This was attributed to the presence of lysophosphatidylcholine in dialyzed serum as this lipid, but not other lipids (e.g., phosphatidylcholine or mitogenic lipids) was able to replace the choline requirement. The choline-deficient effect was not complete; some DNA synthesis occurred in the absence of choline in the medium, and approximately 30% of the cells completed mitosis in 35 h compared to 100% in the presence of choline. The data suggest that phosphatidylcholine is required for normal progression of the cell cycle beyond the G1 phase and is unrelated to the induction of G0 to G1 transition. Choline deficiency should be a useful method for synchronizing cells in the G1 phase.
Tercé
F
F
Lipid and Lipoprotein Research Group, University of Alberta, Edmonton, Canada.
Brun
H
H
Vance
D E
DE
D000818:Animals; D001769:Blood; D002453:Cell Cycle / Q000187:drug effects / Q000502:physiology*; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D002794:Choline / Q000008:administration & dosage; D003470:Culture Media; D004622:Embryo, Mammalian; D005347:Fibroblasts / Q000166:cytology*; D005434:Flow Cytometry; D016193:G1 Phase; D007700:Kinetics; D008244:Lysophosphatidylcholines / Q000378:metabolism; D051379:Mice; D008809:Mice, Inbred C3H; D010713:Phosphatidylcholines / Q000494:pharmacology / Q000502:physiology*; D016192:Resting Phase, Cell Cycle; D016196:S Phase
D003470:Culture Media; D008244:Lysophosphatidylcholines; D010713:Phosphatidylcholines; D002794:Choline